相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increasing the Potency of an Alhydrogel-Formulated Anthrax Vaccine by Minimizing Antigen-Adjuvant Interactions
Allan Watkinson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions
Peter D. Cooper et al.
GLYCOBIOLOGY (2013)
Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice
Riyasat Ali et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody
Nikolai Petrovsky et al.
JOURNAL OF VIROLOGY (2013)
A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing
Fadi Saade et al.
VACCINE (2013)
A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores
Jessica A. Chichester et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine
Erin M. Jackson et al.
PLOS ONE (2012)
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
David L. Gordon et al.
VACCINE (2012)
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
Yoshikazu Honda-Okubo et al.
VACCINE (2012)
Carbohydrate-based immune adjuvants
Nikolai Petrovsky et al.
EXPERT REVIEW OF VACCINES (2011)
Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2→1] poly(fructo-furanosyl) α-D-glucose polymers
Peter D. Cooper et al.
GLYCOBIOLOGY (2011)
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
Anthony D. Cristillo et al.
JOURNAL OF GENERAL VIROLOGY (2011)
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
Mario Lobigs et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants
Hee-Jeong Cho et al.
VACCINE (2010)
Role of Anthrax Toxins in Dissemination, Disease Progression, and Induction of Protective Adaptive Immunity in the Mouse Aerosol Challenge Model
Crystal L. Loving et al.
INFECTION AND IMMUNITY (2009)
Unleashing the therapeutic potential of NOD-like receptors
Kaoru Geddes et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Bacterial cell walls, innate immunity and immunoadjuvants
Jack L. Strominger
NATURE IMMUNOLOGY (2007)
Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults
James D. Campbell et al.
HUMAN VACCINES (2007)
Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route
Aurelie Cleret et al.
JOURNAL OF IMMUNOLOGY (2007)
Murine aerosol challenge model of anthrax
Crystal L. Loving et al.
INFECTION AND IMMUNITY (2007)
Inactivation of Bacillus anthracis spores in murine primary macrophages
Haijing Hu et al.
CELLULAR MICROBIOLOGY (2006)
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial
Geoffrey J. Gorse et al.
VACCINE (2006)
Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities
Brian R. Sloat et al.
PHARMACEUTICAL RESEARCH (2006)
Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine
SF Little et al.
VACCINE (2006)
MDP and other muropeptides - direct and synergistic effects on the immune system
S Traub et al.
JOURNAL OF ENDOTOXIN RESEARCH (2006)
Synergistic effect of Nod1 and Nod2 Agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells
H Tada et al.
INFECTION AND IMMUNITY (2005)
TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
RD Weeratna et al.
VACCINE (2005)
Murine macrophages kill the vegetative form of Bacillus anthracis
TJ Kang et al.
INFECTION AND IMMUNITY (2005)
Dendritic cells endocytose Bacillus anthracis spores:: Implications for anthrax pathogenesis
KC Brittingham et al.
JOURNAL OF IMMUNOLOGY (2005)
Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells
JN Tournier et al.
JOURNAL OF IMMUNOLOGY (2005)
Biological agents with potential for misuse: a historical perspective and defensive measures
DK Bhalla et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Nods and 'intracellular' innate immunity
M Viala et al.
COMPTES RENDUS BIOLOGIES (2004)
The role of Toll-like receptors and Nod proteins in bacterial infection
DJ Philpott et al.
MOLECULAR IMMUNOLOGY (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Effective mucosal immunity to anthrax: Neutralizing antibodies and Th cell responses following nasal immunization with protective antigen
PN Boyaka et al.
JOURNAL OF IMMUNOLOGY (2003)
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001
CM Greene et al.
EMERGING INFECTIOUS DISEASES (2002)
Fate of germinated Bacillus anthracis spores in primary murine macrophages
C Guidi-Rontani et al.
MOLECULAR MICROBIOLOGY (2001)
Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide
V Vidal et al.
IMMUNOLOGY (2001)
Early Bacillus anthracis macrophage interactions:: intracellular survival and escape
TC Dixon et al.
CELLULAR MICROBIOLOGY (2000)
The synthetic immunomodulator Murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells
ECA Darcissac et al.
JOURNAL OF VIROLOGY (2000)
分享论文
